Back to top
more

HealthEquity (HQY)

(Delayed Data from NSDQ)

$98.82 USD

98.82
666,765

+1.62 (1.67%)

Updated Nov 8, 2024 03:59 PM ET

After-Market: $98.64 -0.18 (-0.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (145 out of 250)

Industry: Medical Services

Zacks News

Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think " Yes "

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

HealthEquity (HQY) Gains As Market Dips: What You Should Know

In the latest trading session, HealthEquity (HQY) closed at $81.91, marking a +0.92% move from the previous day.

Urmimala Biswas headshot

Near-Term Outlook for Medical Services Industry Looks Bright

The third-party medical services industry is expanding rapidly.

AMN or HQY: Which Is the Better Value Stock Right Now?

AMN vs. HQY: Which Stock Is the Better Value Option?

HealthEquity (HQY) in Focus: Stock Moves 6.7% Higher

HealthEquity (HQY) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Has HealthEquity (HQY) Outpaced Other Medical Stocks This Year?

Is (HQY) Outperforming Other Medical Stocks This Year?

HealthEquity (HQY) Down 2% Since Last Earnings Report: Can It Rebound?

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AMN vs. HQY: Which Stock Should Value Investors Buy Now?

AMN vs. HQY: Which Stock Is the Better Value Option?

NovoCure (NVCR) Jumps: Stock Rises 7.1%

NovoCure (NVCR) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

HealthEquity (HQY) Set to Acquire WageWorks for $2 Billion

HealthEquity (HQY) is set to acquire WageWorks in an all-cash deal of about $2 billion. The buyout is expected to help HealthEquity to expedite the market-wide transition to HSAs.

Is HealthEquity (HQY) a Great Growth Stock?

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider HealthEquity (HQY).

Teladoc (TDOC) Up 22% in a Year: Will the Rally Continue?

Teladoc's increasing visits and subscriptions are likely to aid revenue growth. This will further drive its share price.

Zacks.com featured highlights include: Comcast, Enterprise Products, HealthEquity and Pioneer Natural

Zacks.com featured highlights include: Comcast, Enterprise Products, HealthEquity and Pioneer Natural

Tirthankar Chakraborty headshot

4 of the Best Stocks to Buy for Superb Earnings Growth

We select four stocks that have striking earnings growth and positive estimate revisions.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for June 7th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday

HealthEquity (HQY) Earnings & Revenues Top Estimates in Q1

Higher revenues, solid segmental performance and expansion in margins benefit HealthEquity's (HQY) Q1 earnings.

HealthEquity (HQY) Tops Q1 Earnings and Revenue Estimates

HealthEquity (HQY) delivered earnings and revenue surprises of 20.59% and 3.65%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?

ICLR or HQY: Which Is the Better Value Stock Right Now?

ICLR vs. HQY: Which Stock Is the Better Value Option?

HealthEquity (HQY) Down 16.1% Since Last Earnings Report: Can It Rebound?

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PRAH vs. HQY: Which Stock Is the Better Value Option?

PRAH vs. HQY: Which Stock Is the Better Value Option?

HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q4

HealthEquity (HQY) witnesses strong HSA member growth in the fourth quarter of fiscal 2019.

PRAH vs. HQY: Which Stock Should Value Investors Buy Now?

PRAH vs. HQY: Which Stock Is the Better Value Option?

HealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings Growth

HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HealthEquity (HQY) Surges: Stock Moves 8.6% Higher

HealthEquity (HQY) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

HealthEquity's (HQY) Preliminary Q4 Results Cheer Investors

HealthEquity's (HQY) solid guidance for fiscal 2019 favors stock.